Pharm Exec Podcast
Pharmaceutical Executive Daily: September 24, 2025
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:02:39
- Mas informaciones
Informações:
Sinopsis
In today’s Pharmaceutical Executive Daily, we cover the market reaction to Trump’s Tylenol–autism claim, the FDA’s complete response letter to Scholar Rock for its spinal muscular atrophy treatment, and a closer look at the state of evidence linking Tylenol use and autism risk.
